Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-05-28 7:39 pm Unchanged | 2024-05-28 | 13D | Carisma Therapeutics, Inc. CARM | HealthCap VII L.P. | 3,398,248 8.200% | 0 (Unchanged) | Filing History |
| 2024-03-13 4:30 pm Purchase | 2023-12-31 | 13G | Carisma Therapeutics, Inc. CARM | AbbVie Biotechnology Ltd | 2,749,855 6.800% | 2,749,855 (New Position) | Filing History |
| 2024-03-07 4:05 pm Unchanged | 2024-03-07 | 13D | Carisma Therapeutics, Inc. CARM | HealthCap VII L.P. | 3,398,248 8.400% | 0 (Unchanged) | Filing History |
| 2024-02-13 5:00 pm Purchase | 2023-12-29 | 13G | Carisma Therapeutics, Inc. CARM | The Vanguard Group | 1,568,761 3.890% | 1,568,761 (New Position) | Filing History |
| 2024-02-02 1:06 pm Sale | 2023-12-31 | 13G | Carisma Therapeutics, Inc. CARM | Longview Innovation Corp. | 2,713,232 6.700% | -182,033 (-6.29%) | Filing History |
| 2024-01-26 4:31 pm Sale | 2023-09-15 | 13D | Carisma Therapeutics, Inc. CARM | TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 1,252,107 3.100% | -930,705 (-42.64%) | Filing History |
| 2023-03-22 11:13 am Sale | 2023-03-22 | 13D | Carisma Therapeutics, Inc. CARM | HealthCap VII L.P. | 3,398,248 8.400% | -181,363 (-5.07%) | Filing History |
| 2023-03-17 4:10 pm Purchase | 2023-03-17 | 13D | Carisma Therapeutics, Inc. CARM | TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2,182,812 5.420% | 2,182,812 (New Position) | Filing History |
| 2023-03-16 4:08 pm Purchase | 2023-03-07 | 13G | Carisma Therapeutics, Inc. CARM | Longview Innovation Corp. | 2,895,265 7.200% | 2,895,265 (New Position) | Filing History |
| 2023-03-13 5:12 pm Purchase | 2023-03-07 | 13G | Sesen Bio, Inc. SESN | ModernaTX Inc. | 5,059,338 12.570% | 5,059,338 (New Position) | Filing History |
| 2023-03-09 10:33 am Purchase | 2023-03-07 | 13D | Carisma Therapeutics, Inc. CARM | HealthCap VII L.P. | 3,579,611 8.900% | 3,579,611 (New Position) | Filing History |
| 2023-02-15 4:54 pm Purchase | 2023-02-13 | 13D | Sesen Bio, Inc. SESN | Radoff Bradley Louis | 465,005 4.600% | 19,250 (+4.32%) | Filing History |
| 2023-02-09 11:32 am Sale | 2022-12-30 | 13G | Sesen Bio, Inc. SESN | The Vanguard Group | 542,715 5.350% | -75,623 (-12.23%) | Filing History |
| 2023-01-26 09:25 am Purchase | 2023-01-25 | 13D | Sesen Bio, Inc. SESN | Radoff Bradley Louis | 445,755 4.400% | 13,662 (+3.16%) | Filing History |
| 2023-01-05 2:38 pm Purchase | 2023-01-03 | 13D | Sesen Bio, Inc. SESN | Radoff Bradley Louis | 432,093 4.300% | 57,088 (+15.22%) | Filing History |
| 2022-12-01 3:39 pm Purchase | 2022-11-29 | 13D | Sesen Bio, Inc. SESN | Radoff Bradley Louis | 375,005 3.700% | 75,005 (+25.00%) | Filing History |
| 2022-11-18 1:31 pm Purchase | 2022-11-09 | 13D | Sesen Bio, Inc. SESN | Radoff Bradley Louis | 300,000 3.000% | 300,000 (New Position) | Filing History |
| 2022-07-08 4:56 pm Sale | 2022-06-30 | 13G | Sesen Bio, Inc. SESN | BlackRock Inc. BLK | 204,433 2.000% | -469,997 (-69.69%) | Filing History |
| 2022-02-10 08:37 am Purchase | 2021-12-31 | 13G | Sesen Bio, Inc. SESN | The Vanguard Group | 618,338 6.200% | 618,338 (New Position) | Filing History |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Sesen Bio, Inc. SESN | BlackRock Inc. BLK | 674,430 6.800% | 674,430 (New Position) | Filing History |